References
- Cancer statistics. New York; Am Cancer Society. NY Chapter, 1988
- MacMahon B. Risk factors for cancer of the pancreas. Cancer 1982: 50(11 Suppl): 2676–80
- Wynder EL. An epidemiological evaluation of the causes of cancer of the pancreas. Cancer Res 1975: 35(8): 2228–33
- Campbell JP, Wilson SR. Pancreatic neoplasms: how useful is evaluation with US? Radiology 1988: 167(2): 341–4
- Moss AA, Federie M, Shapiro HA. et al. The combined use of computed tomography and endoscopic retrograde cholangiopancreatography in the assessment of suspected pancreatic neoplasm: a blind clinical evaluation. Radiology 1980: 134(1): 159–63
- Freeny PC, Ball TJ. Evaluation of endoscopic retrograde cholangiopancreatography and angiography in the diagnosis of pancreatic carcinoma. AJR 1978: 130(4): 683–91
- Hall-Craggs MA, Lees WR. Fine-needle aspiration biopsy: pancreatic and biliary tumors. AJR 1986: 147(2): 399–403
- Connolly MM, Dawson PJ, Michelassi F. et al. Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987: 206(3): 366–73
- Bornman PC, Harries-Jones EP, Tobias R, et al. Prospective continued trial of transhepatic biliary endoprosthesis versus bypass surgery for incurable carcinoma of head of pancreas. Lancet 1986: 1(8472): 69–71
- Brandabur JJ, Kozarek RA, Ball TJ, et al. Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis. Am J Gastroenterol 1988: 83(10): 1132–9
- Schouten JT. Operative therapy for pancreatic carcinoma. Am J Surg 1986: 151(5): 626–30
- Cancer of the Pancreas Task Force. Staging of cancer of the pancreas. Cancer 1981: 47(6 Suppl): 1631–9
- Moertel CG, Frytak S, Hahn RG, et al. Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: the Gastrointestinal Tumor Study Group. Cancer 1981: 48(8): 1705–10
- Bukowski RM, Balcerzak SP, O'Bryan RM, et al. Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer: a Southwest Oncology Group study. Cancer 1983: 52(9): 1577–82